Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting® 2024, hosted by the ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Liver fibrosis causes scar tissue to form on the liver, sometimes leading to chronic liver disease. Learn about noninvasive ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for ...

Three years after raising $100 million in series A funds, the Atlas Venture-backed biotech has chosen a lead drug candidate.

Ultra-processed food consumption in obese adolescents is linked to insulin resistance and liver disease, stressing the need ...

The London-based biotechnology company said the non-dilutive funding will support its ongoing development of its lead gene therapy, GF-1002, for the treatment of metabolic associated steatohepatitis, ...

Professor Ramou Njie made this disclosure recently during her presentation as part of activities marking liver cancer ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease – the leading cause of death worldwide.   University of Leeds ...

A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease – the leading cause of death worldwideNew Delhi: University of ...

Last week, BioVie announced a significant milestone: a Notice of Allowance from the Japan Patent Office for its application regarding a novel liquid formulation of terlipressin. This formulation, ...

An FDA AdCom in September recommended against full approval for Ocaliva by a 13-1 vote for the treatment of primary biliary ...